1887

Abstract

The genomes of commonly used variants of human cytomegalovirus (HCMV) strains Towne and AD169 each contain a substantial mutation in which a region (U/) at the right end of the long unique region has been replaced by an inverted duplication of a region from the left end of the genome. Using high-throughput technology, we have sequenced HCMV strain Towne (ATCC VR-977) and confirmed the presence of two variants, one exhibiting the replacement in U/ and the other intact in this region. Both variants are mutated in genes RL13, UL1, UL40, UL130, US1 and US9. We have also sequenced a novel AD169 variant (varUC) that is intact in U/ except for a small deletion that affects genes UL144, UL142, UL141 and UL140. Like other AD169 variants, varUC is mutated in genes RL5A, RL13, UL36 and UL131A. A subpopulation of varUC contains an additional deletion affecting genes IRS1, US1 and US2.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.013250-0
2009-10-01
2021-03-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/10/2375.html?itemId=/content/journal/jgv/10.1099/vir.0.013250-0&mimeType=html&fmt=ahah

References

  1. Akter P., Cunningham C., McSharry B. P., Dolan A., Addison C., Dargan D. J., Hassan-Walker A. F., Emery V. C., Griffiths P. D. other authors 2003; Two novel spliced genes in human cytomegalovirus. J Gen Virol 84:1117–1122 [CrossRef]
    [Google Scholar]
  2. Bradley A. J., Kovács I. J., Gatherer D., Dargan D. J., Alkharsah K. R., Chan P. K. S., Carman W. F., Dedicoat M., Emery V. C. other authors 2008; Genotypic analysis of two hypervariable human cytomegalovirus genes. J Med Virol 80:1615–1623 [CrossRef]
    [Google Scholar]
  3. Brown J. M., Kaneshima H., Mocarski E. S. 1995; Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis 171:1599–1603 [CrossRef]
    [Google Scholar]
  4. Cha T.-A., Tom E., Kemble G. W., Duke G. M., Mocarski E. S., Spaete R. R. 1996; Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70:78–83
    [Google Scholar]
  5. Chalupny N. J., Rein-Weston A., Dosch S., Cosman D. 2006; Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun 346:175–181 [CrossRef]
    [Google Scholar]
  6. Chee M. S., Bankier A. T., Beck S., Bohni R., Brown C. M., Cerny R., Horsnell T., Hutchison C. A., III, Kouzarides T. other authors 1990; Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154:125–169
    [Google Scholar]
  7. Cheung T. C., Humphreys I. R., Potter K. G., Norris P. S., Shumway H. M., Tran B. R., Patterson G., Rochelle J.-J., Yoon M. other authors 2005; Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci U S A 102:13218–13223 [CrossRef]
    [Google Scholar]
  8. Craig J. M., Macauley J. C., Weller T. H., Wirth P. 1957; Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med 94:4–12 [CrossRef]
    [Google Scholar]
  9. Dargan D. J., Jamieson F. E., MacLean J., Dolan A., Addison C., McGeoch D. J. 1997; The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43. J Virol 71:9833–9836
    [Google Scholar]
  10. Davison A. J., Akter P., Cunningham C., Dolan A., Addison C., Dargan D. J., Hassan-Walker A. F., Emery V. C., Griffiths P. D., Wilkinson G. W. G. 2003a; Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes. J Gen Virol 84:657–663 [CrossRef]
    [Google Scholar]
  11. Davison A. J., Dolan A., Akter P., Addison C., Dargan D. J., Alcendor D. J., McGeoch D. J., Hayward G. S. 2003b; The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 84:17–28 [CrossRef]
    [Google Scholar]
  12. Dolan A., Cunningham C., Hector R. D., Hassan-Walker A. F., Lee L., Addison C., Dargan D. J., McGeoch D. J., Gatherer D. other authors 2004; Genetic content of wild-type human cytomegalovirus. J Gen Virol 85:1301–1312 [CrossRef]
    [Google Scholar]
  13. Dunn W., Chou C., Li H., Hai R., Patterson D., Stolc V., Zhu H., Liu F. 2003; Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100:14223–14228 [CrossRef]
    [Google Scholar]
  14. Elek S. D., Stern H. 1974; Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet 1:1–5
    [Google Scholar]
  15. Hahn G., Rose D., Wagner M., Rhiel S., McVoy M. A. 2003; Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Townelong as BACs and site-directed mutagenesis using a PCR-based technique. Virology 307:164–177 [CrossRef]
    [Google Scholar]
  16. Hahn G., Revello M. G., Patrone M., Percivalle E., Campanini G., Sarasini A., Wagner M., Gallina A., Milanesi G. other authors 2004; Human cytomegalovirus UL131–128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78:10023–10033 [CrossRef]
    [Google Scholar]
  17. Kemble G., Duke G., Winter R., Spaete R. 1996; Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids. J Virol 70:2044–2048
    [Google Scholar]
  18. Li H., Ruan J., Durbin R. 2008; Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18:1851–1858 [CrossRef]
    [Google Scholar]
  19. Marchini A., Liu H., Zhu H. 2001; Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 75:1870–1878 [CrossRef]
    [Google Scholar]
  20. Mocarski E. S., Prichard M. N., Tan C. S., Brown J. M. 1997; Reassessing the organization of the UL42–UL43 region of the human cytomegalovirus strain AD169 genome. Virology 239:169–175 [CrossRef]
    [Google Scholar]
  21. Murphy E., Yu D., Grimwood J., Schmutz J., Dickson M., Jarvis M. A., Hahn G., Nelson J. A., Myers R. M., Shenk T. E. 2003; Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 100:14976–14981 [CrossRef]
    [Google Scholar]
  22. Oram J. D., Downing R. G., Akrigg A., Dollery A. A., Duggleby C. J., Wilkinson G. W. G., Greenaway P. J. 1982; Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome. J Gen Virol 59:111–129 [CrossRef]
    [Google Scholar]
  23. Plotkin S. A., Furukawa T., Zygraich N., Huygelen C. 1975; Candidate cytomegalovirus strain for human vaccination. Infect Immun 12:521–527
    [Google Scholar]
  24. Poole E., Atkins E., Nakayama T., Yoshie O., Groves I., Alcami A., Sinclair J. 2008; NF- κ B-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86. J Virol 82:4250–4256 [CrossRef]
    [Google Scholar]
  25. Prichard M. N., Penfold M. E. T., Duke G. M., Spaete R. R., Kemble G. W. 2001; A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev Med Virol 11:191–200 [CrossRef]
    [Google Scholar]
  26. Rasmussen L., Geissler A., Winters M. 2003; Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J Infect Dis 187:809–819 [CrossRef]
    [Google Scholar]
  27. Rowe W. P., Hartley J. W., Waterman S., Turner H. C., Huebner R. J. 1956; Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med 92:418–424 [CrossRef]
    [Google Scholar]
  28. Sinzger C., Digel M., Jahn G. 2008a; Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 325:63–83
    [Google Scholar]
  29. Sinzger C., Hahn G., Digel M., Katona R., Sampaio K. L., Messerle M., Hengel H., Koszinowski U., Brune W., Adler B. 2008b; Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89:359–368 [CrossRef]
    [Google Scholar]
  30. Skaletskaya A., Bartle L. M., Chittenden T., McCormick A. L., Mocarski E. S., Goldmacher V. S. 2001; A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A 98:7829–7834 [CrossRef]
    [Google Scholar]
  31. Smith M. G. 1956; Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med 92:424–430 [CrossRef]
    [Google Scholar]
  32. Smith J. D., de Harven E. 1973; Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. I. Sequence of viral replication. J Virol 12:919–930
    [Google Scholar]
  33. Tomasec P., Braud V. M., Rickards C., Powell M. B., McSharry B. P., Gadola S., Cerundolo V., Borysiewicz L. K., McMichael A. J., Wilkinson G. W. G. 2000; Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287:1031–1033 [CrossRef]
    [Google Scholar]
  34. Tomasec P., Wang E. C., Davison A. J., Vojtesek B., Armstrong M., Griffin C., McSharry B. P., Morris R. J., Llewellyn-Lacey S. other authors 2005; Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6:181–188
    [Google Scholar]
  35. Vonka V., Benyesh-Melnick M. 1966; Interactions of human cytomegalovirus with human fibroblasts. J Bacteriol 91:213–220
    [Google Scholar]
  36. Wills M. R., Ashiru O., Reeves M. B., Okecha G., Trowsdale J., Tomasec P., Wilkinson G. W. G., Sinclair J., Sissons J. G. P. 2005; Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 175:7457–7465 [CrossRef]
    [Google Scholar]
  37. Yu D., Smith G. A., Enquist L. W., Shenk T. 2002; Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J Virol 76:2316–2328 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.013250-0
Loading
/content/journal/jgv/10.1099/vir.0.013250-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error